Researchers at the U-M Rogel Cancer Center may have found a new way to treat an aggressive form of breast cancer. Duxin Sun, Ph.D., and professor at the College of Pharmacy led the study, finding that targeting the immune microenvironment in lymph nodes and tumors simultaneously led to long-term tumor remission in mice. The faculty expert explains how he and his team identified the new approach, using nanoparticles to increase the efficacy and his hopes for a clinical trial.
